1Sudoh T,Kangawa K,Minamino N,et a1.A new natriuretic peptidein porcine brain[J].Nature,1988,332(6159):78-81.
2Das BB,Solinger R.Role of natriuretic peptide family in cardio-vascular medicine[J].Cardiovasc Hematol Agents Med Chem,2009,7(1):29-42.
3Sumida H,Yasue H,Yoshimura M,et al Comparison of secretionpattern between A-type and B-type natriuretic peptides in patientswith old myocardial infarction FREE[J].J Am Coll Cardiol,1995,25(5):1105-1110.
4Kone BC.Molecular biology of natriuretic peptides and nitric oxidesynthases[J].Cardiovasc Res,2001,51(3):429-441.
5Biro E,Toth G,Telegdy G.Effect of receptor blockers on brainnatriuretic peptide and C-type natriuretic peptide caused anxiolyticstate in rats[J].Neuropeptides,1996,30(1):59-65.
6Morita E,Yasue H,YoshimuraM,et a1.Increased plasma levels ofbrainnatriuretic peptide in patients with acute myocardial infarction[J].Circulation,1993,88(1):82-91.
7Hirayama A,Kusuoka H,Yamamoto H,et al.Usefulness of plasma brainnatriuretic pep tide concentration for predicting subsequent leftventricular remodeling after coronary angiop-lasty in patientswith acute myocardial infarction[J].Am J Cardiol,2006,98(4):453-457.
8Jerberg T,Lindahl B,Siegbaim A,et a1.N-terminal probrain natriu-retic peptide in relation to inflammation,myocardial nerosis andthe effects of invasive strategy in unstable coronary artery diease[J].J Am Coll Cardial,2003,42(11):1909-1916.
9Francis GS,Benedictc,Johnstoned E,etal.Comparison of neuroen-docrine activation in patients with left ventricular dysfunction withand without congestive heart failure:a substudy of the studies ofleft ventricular dysfunction(SOLVD)[J].Circular,1990,82(5):1724-1729.
10Swiatkiewicz I,Grubecki A,Kozinski M,et al.NT-proBNP andechocardiography for long-term left ventricular function assessmentafter acute myocardial infarction treated with primary angioplasty[J].Pol Merkur Lekarski,2006,20(117):289-292.
二级参考文献8
1Anand IS, Fisher LD, Chiang YT, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation ,2003,107 : 1278-1283.
2de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med, 2001,345:1014-1021.
3Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation, 1996,93 : 1963-1969.
4Meier MA, AlBadr WH, Cooper JV, et al. The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med, 2002, 162 : 1585-1589.
5Ravkilde J, Horder M, Gerhardt W, et al. Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. Scand J Clin Lab Invest, 1993,53: 677- 685.
6Tapanainen JM, Lindgren KS, Makikallio TH, et al. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol,2004,43:757-763.
7Richards AM, Nicholls MG, Espiner EA, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation, 2003,107:2786-2792.
8Richards AM, NichoUs MG, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation, 1998,97 : 1921-1929.
7Gegenhuber A,Mueller 丁,Firlinger F,et al_ Timer courseof B-type natriuretic peptide ( BNP) and N-terminal pro-BNP changes in patients with decompensated heart failure[J]. Clin Chem,2004.50(3) :454-456.
8Limkakeng AT,Drake W,Mani G,et al. Left ventriculardysfunction screening in hypertensive patients with N-term inal pro-B-type natriuretic peptide and electrocardio-gram[J]. Am J Emerg Med,2012,30(1) :214-217.
9Garcia S, Akbar MS, Ali SS,et al. N. terufinal pro B-typenatriuretic peptide predicts mortality in patients with leftventrieular hypertrophy[J], Int J Cardiol, 2010 ,143 (3):349-352.
10Woriskoon S, Pollar M, Jaroensutasinee M. PredictingDHF incidence in northern Thailand using time series a-nalysis technique[J], Intern J Biol Med Sci, 2009,4 (3):1017-1020.
